Researchers have created a highly detailed cellular map of Alzheimer’s disease progression, revealing new insights into the ...

Dementia is a challenging condition that impacts millions of people around the world. It causes a gradual decline in thinking ...

It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

The North Bay Regional Health Centre (NBRHC) has transformed its dementia care unit into a ‘neighbourhood’ to help reduce ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

Today, AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington announced the Dementia Risk ...

A once-a-day pill that targets the production of the stress hormone cortisol in the brain has the potential to be the “holy ...

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...

Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked. Among a group ...